Document is current
Any future updates will be listed below
-
Authors
Justesen, Josefine Freyberg
Wadström, Benjamin Nilsson
Marott, Sarah Caroline Weisenfeldt
Landt, Eskild Morten
Nordestgaard, Børge Grønne
Afzal, Shoaib
Dahl, Morten
- License Information
-
More Information
Article History
Received: 1 September 2025
Accepted: 9 April 2026
First Online: 15 April 2026
Declarations
:
: The CPGS was conducted according to the Helsinki Declaration and approved by institutional boards and Danish ethical committees (KF-100.2039/91, KF-01-144/01, H-KF-01-144/01). Written informed consent was obtained from each participant prior to enrolment. The UK Biobank study was approved by a Research Ethics Committee (REC; approval number: 11/NW/0382), and all participants provided written informed consent.
: BGN discloses consultancies with Abbott, Akcea, Amarin, Amgen, Arrowhead, AstraZeneca, Denka, Esperion, Kowa, Lilly, Mankind, Marea Therapeutics, Novartis, Novo Nordisk, Regeneron, Sanofi, Silence Therapeutics, Torrent, Ultragenyx, and UVS. JFJ, BNW, SCWM, EML, SA, and MD declare that they have no competing interests.
